Table 2.
Parameter | Group | I | II | p | 2-way ANOVA |
---|---|---|---|---|---|
TOS/TOC [umol/L] | NW | 150.30 ± 81.29 | 165.8 ± 92.57 | 0.04* | *interaction, row factor, time |
OB | 487.78 ± 220.77 | 451.57 ± 206.47 | 0.12 | ||
p1 (NW I vs OB I) = 0.0001#; p2 (NW II vs OB II) = 0.0003# | |||||
TAS/TAC [umol/L] | NW | 347.6 ± 39.09 | 339.9 ± 29.15 | 0.62 | *row factor |
OB | 357.14 ± 45.56 | 357.64 ± 43.11 | 0.94 | ||
p1 (NW I vs OB I) = 0.40 p2 (NW II vs OB II) = 0.23 | |||||
OSI | NW | 0.43 ± 0.20 | 0.49 ± 0.26 | 0.08 | *interaction, row factor, time |
OB | 1.47 ± 0.69 | 1.27 ± 0.59 | 0.16 | ||
p1 (NW I vs OB I) = 0.0001#; p2(NW II vs OB II) = 0.0008# | |||||
CAT [µg/Hb] | NW | 188.06 ± 25.31 | 189.30 ± 28.34 | 0.88 | *interaction, time |
OB | 195.85 ± 25.15 | 220.90 ± 39.40 | 0.01* | ||
p1 (NW I vs OB I) = 0.46; p2 (NW II vs OB II) = 0.04# | |||||
SOD1 [µg/Hb] | NW | 1460.83 ± 262.68 | 1261.85 ± 132.51 | 0.03* | ns. |
OB | 1226.42 ± 136.19 | 1384.28 ± 227.48 | 0.04* | ||
p1 (NW I vs OB I) = 0.01#; p2 (NW II vs OB II) = 0.14 | |||||
GPx [µg/Hb] | NW | 25.38 ± 1.75 | 24.67 ± 2.15 | 0.52 | ns. |
OB | 26.32 ± 4.43 | 28.04 ± 4.74 | 0.37 | ||
p1 (NW I vs OB I) = 0.53; p2 (NW II vs OB II) = 0.04# | |||||
CAT/SOD1 Ratio | NW | 0.13 ± 0.03 | 0.15 ± 0.03 | 0.10 | *interaction, time |
OB | 0.16 ± 0.02 | 0.16 ± 0.04 | 0.84 | ||
p1 (NW I vs OB I) = 0.02#; p2 (NW II vs OB II) = 0.47 |
NW – volunteers with normal BMI, OB – volunteers with BMI> 35, I – data obtained before the experiment; II – data obtained after 20th cryotherapy.